Wang Shou-Cheng, Shih Hou-Yu, He Jie-Long, Chen Jaw-Chyun, Wang Yun-Chi, Tsai Chia-Wen, Chang Wen-Shin, Hsia Te-Chun, Bau DA-Tian
Taichung Armed Forces General Hospital, Taichung, Taiwan, R.O.C.
National Defense Medical Center, Taipei, Taiwan, R.O.C.
In Vivo. 2025 Jul-Aug;39(4):1852-1863. doi: 10.21873/invivo.13985.
BACKGROUND/AIM: Vitamin D plays a critical role in regulating immune function. In literature, several studies have indicated that variations in the vitamin D receptor gene () may be associated with the risk of asthma risk. However, the findings remain inconsistent. The current study aimed to assess the influence of polymorphisms on both asthma risk and severity.
A cohort comprising 453 non-asthmatic healthy controls and 198 asthmatic cases was assembled, and the rs731236, rs1544410, rs2228570, and rs7975232 genotypes were determined utilizing polymerase chain reaction-restriction fragment length polymorphism methodology.
Our findings indicated that people carrying the variant AG and AA genotypes of rs2228570 demonstrated an elevated risk of asthma compared to wild-type GG carriers (odds ratio=1.55 and 2.19, 95% confidence interval=1.02-2.35 and 1.37-3.49; =0.0507 and 0.0014, respectively). Furthermore, individuals carrying the variant A allele at rs2228570 exhibited a higher risk of asthma than those carrying the wild-type G allele (odds ratio=1.51, 95% confidence interval=1.19-1.92; =0.0008). Moreover, a significant association was observed between rs2228570 A-carrying genotypes and increased the severity of asthma symptoms among asthmatic patients ( for trend=0.0024).
The variant A allele at rs2228570 was associated with higher asthma susceptibility, and may serve as a predictor for asthma symptom severity. Our findings encouraged further validation in larger and diverse populations to further elucidate the significance of genotype in asthma development.
背景/目的:维生素D在调节免疫功能中起关键作用。在文献中,多项研究表明维生素D受体基因()的变异可能与哮喘风险相关。然而,研究结果仍不一致。本研究旨在评估多态性对哮喘风险和严重程度的影响。
组建了一个包含453名非哮喘健康对照者和198名哮喘患者的队列,并采用聚合酶链反应-限制性片段长度多态性方法确定维生素D受体基因rs731236、rs1544410、rs2228570和rs7975232的基因型。
我们的研究结果表明,与野生型GG携带者相比,携带维生素D受体基因rs2228570变异型AG和AA基因型的人患哮喘的风险升高(优势比分别为1.55和2.19,95%置信区间为1.02 - 2.35和1.37 - 3.49;P值分别为0.0507和0.0014)。此外,携带维生素D受体基因rs2228570变异型A等位基因的个体患哮喘的风险高于携带野生型G等位基因的个体(优势比为1.51,95%置信区间为1.19 - 1.92;P值为0.0008)。此外,在哮喘患者中,观察到携带维生素D受体基因rs2228570 A的基因型与哮喘症状严重程度增加之间存在显著关联(趋势P值 = 0.0024)。
维生素D受体基因rs2228570的变异型A等位基因与较高的哮喘易感性相关,并且可能作为哮喘症状严重程度的预测指标。我们的研究结果鼓励在更大且多样化的人群中进行进一步验证,以进一步阐明该基因型在哮喘发生发展中的意义。